Literature DB >> 3266294

The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation.

W W Stewart1, A Johnson, M W Steward, K Whaley, M A Kerr.   

Abstract

Radioimmunoassays for C3a and C4a have been used to measure the activation of complement in human serum by immune complexes containing DNP-BSA and each of 11 mouse anti-DNP monoclonal antibodies of varied isotype and affinity. When preformed complexes were added to serum, those containing IgG2 or IgM were potent activators of C4, whilst IgG1 complexes were less efficient. C3 activation in normal serum was similar for complexes containing IgG1, IgG2a, IgG2b or IgM. IgA complexes did not activate C3 or C4. Solubilisation of complexes was greatest for IgM and IgG2b and least for IgG2a and IgA. In serum containing Mg2+ EGTA C4 activation was abolished and the amount of C3 activation was lower for all IgG and IgM complexes. Antibodies of the same isotype did not necessarily activate complement to the same extent. Unexpectedly, three of the four IgMs activated C3 in EGTA. For IgMs, neither complement activation nor solubilisation correlated with affinity. For IgG1 antibodies, solubilisation was inversely proportional to affinity. C3 or C4 activation did not correlate with affinity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266294     DOI: 10.1016/0161-5890(88)90051-x

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

Review 1.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

2.  Activation of human complement by mouse and mouse/human chimeric monoclonal antibodies.

Authors:  J Seino; P Eveleigh; S Warnaar; L J van Haarlem; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

3.  Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.

Authors:  I Yokoyama; F Waxman
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

4.  Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum.

Authors:  Susheel K Singh; Susan Thrane; Bishwanath K Chourasia; Karina Teelen; Wouter Graumans; Rianne Stoter; Geert-Jan van Gemert; Marga G van de Vegte-Bolmer; Morten A Nielsen; Ali Salanti; Adam F Sander; Robert W Sauerwein; Matthijs M Jore; Michael Theisen
Journal:  Front Immunol       Date:  2019-06-05       Impact factor: 7.561

5.  Complement Regulator FHR-3 Is Elevated either Locally or Systemically in a Selection of Autoimmune Diseases.

Authors:  Nicole Schäfer; Antje Grosche; Joerg Reinders; Stefanie M Hauck; Richard B Pouw; Taco W Kuijpers; Diana Wouters; Boris Ehrenstein; Volker Enzmann; Peter F Zipfel; Christine Skerka; Diana Pauly
Journal:  Front Immunol       Date:  2016-11-28       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.